Literature DB >> 3618882

Encapsulated papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years.

H L Evans.   

Abstract

Fourteen cases of encapsulated papillary thyroid neoplasm in which extracapsular extension was not observed and a minimum of 10 years follow-up was available are herein presented. The cases were divided into three categories: encapsulated papillary carcinomas (five cases), which had cytologic features typical of papillary thyroid carcinoma (vesicular or indented nuclei) and an entirely or predominantly thick capsule with capsular invasion; encapsulated papillary neoplasms of undetermined malignancy (seven cases), in which the cytologic features were also typical of papillary carcinoma but the capsule was predominantly thin (less than 0.1 mm thick) or was thick without capsular invasion; and follicular adenomas with papillae (two cases), which resembled follicular adenomas cytologically (rounded, stippled nuclei and Hürthle cell change) but contained a significant number of papillary structures (both cases had an entirely or predominantly thin capsule). The only evidence of malignant behavior in the entire series was a cervical lymph node metastasis in one case of encapsulated papillary carcinoma; the "encapsulated papillary neoplasms of undetermined malignancy" were so labeled because other authors have reported "encapsulated papillary carcinomas without capsular invasion" and it was therefore thought that the malignant potential of this category is as yet best considered undefined.

Entities:  

Mesh:

Year:  1987        PMID: 3618882     DOI: 10.1097/00000478-198708000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Encapsulated papillary thyroid carcinoma: is it a distinctive clinical entity with low-grade malignancy?

Authors:  A Pisanu; D Deplano; I Reccia; G Porceddu; A Uccheddu
Journal:  J Endocrinol Invest       Date:  2012-01-31       Impact factor: 4.256

2.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

3.  How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

Authors:  Bin Xu; Rene Serrette; R Michael Tuttle; Bayan Alzumaili; Ian Ganly; Nora Katabi; Giovanni Tallini; Ronald Ghossein
Journal:  Thyroid       Date:  2019-10-10       Impact factor: 6.568

4.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

5.  Papillary thyroid cancer, macrofollicular variant: the follow-up and analysis of prognosis of 5 patients.

Authors:  Varlık Erol; Ozer Makay; Yeşim Ertan; Gökhan Içöz; Mahir Akyıldız; Mustafa Yılmaz
Journal:  J Thyroid Res       Date:  2014-09-10

6.  Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis.

Authors:  Chenghao Jiang; Tong Cheng; Xucai Zheng; Shikai Hong; Song Liu; Jianjun Liu; Jing Wang; Shengying Wang
Journal:  Cancer Manag Res       Date:  2018-03-09       Impact factor: 3.989

7.  Capsular Invasion Matters Also in "Papillary Patterned" Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma.

Authors:  Dilara Akbulut; Ezgi Dicle Kuz; Nazmiye Kursun; Serpil Dizbay Sak
Journal:  Endocr Pathol       Date:  2021-01-04       Impact factor: 3.943

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.